NDC 54771-5278 - Spectramast DC

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
54771-5278
Package NDCs from labels
54771-5278-1, 54771-5278-2
Manufacturer
Zoetis Inc.
Effective date
2025-03-26
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
SPECTRAMAST ® DCZoetis Inc.2025-03-26PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54771-5278-1SpectramastDC12 in 1 CARTONSUSPENSION125
54771-5278-1SpectramastDC10 mL in 1 SYRINGESUSPENSION105
54771-5278-2SpectramastDC144 in 1 PAILSUSPENSION1445
54771-5278-2SpectramastDC10 mL in 1 SYRINGESUSPENSION105

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54771-5278SPECTRAMAST DC (CEFTIOFUR HYDROCHLORIDE) SUSPENSION [ZOETIS INC.]54 package rows20250402_eea5a063-8583-4f9b-8377-aa4c7e9fd302.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ceftiofur hydrochlorideACTIVE INGREDIENT6822A07436SPECTRAMAST DC (CEFTIOFUR HYDROCHLORIDE) INJECTION, SOLUTION [ZOETIS INC.]1
ceftiofurACTIVE MOIETY83JL932I1CSPECTRAMAST DC (CEFTIOFUR HYDROCHLORIDE) INJECTION, SOLUTION [ZOETIS INC.]1
microcrystalline waxINACTIVE INGREDIENTXOF597Q3KYSPECTRAMAST DC (CEFTIOFUR HYDROCHLORIDE) INJECTION, SOLUTION [ZOETIS INC.]1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.